The Crisis
The Global Healthcare CrisisKEMIRIX Was Built to End
A data-driven look at the preventable burden — and why Africa cannot afford to wait for solutions built for someone else.
Global Scale
The Numbers Are Not Statistics. They Are Lives.
Every year, preventable medical errors kill more people than road accidents, diabetes, or breast cancer combined. These deaths are not inevitable — they are the result of systems that were not designed to catch them.
Preventable deaths from diagnostic errors annually
WHO, 2023
Leading cause of in-hospital death: Adverse Drug Reactions
FDA, 2022
People with zero access to essential health services
WHO, 2023
Deaths annually from drug-drug interactions in the US alone
JAMA, 2022
Africa-Specific
Africa Faces a Compounded Crisis
The global burden of medical errors hits Africa harder — not because African clinicians are less capable, but because the tools they need do not exist for their context.
G6PD deficiency prevalence in West Africa
Most prescription drugs were tested on populations without G6PD deficiency. Prescribing these drugs in West Africa without genetic screening causes haemolysis, organ failure, and death.
Population-scale PGx infrastructure in sub-Saharan Africa
Pharmacogenomics — the science of how genes affect drug response — has transformed prescribing in Europe and North America. Sub-Saharan Africa has zero comparable infrastructure, despite having the most genetically diverse population on Earth.
Doctor-to-patient ratio in some sub-Saharan African regions
The WHO recommends 1 doctor per 1,000 patients. In parts of sub-Saharan Africa, the ratio is 1 to 5,000. Clinical decision support is not a luxury here — it is a force multiplier for a severely under-resourced system.
African patients who use traditional medicine alongside pharmaceuticals
Most clinical AI systems have zero data on traditional medicine interactions. When 80% of your patient population is combining herbal preparations with pharmaceuticals, and your CDS tool has no awareness of this, you are flying blind.
The Gap
Two Worlds of Healthcare. One Planet.
The technology to prevent most of these deaths already exists. It is simply not available in the places where the burden is highest.
| Clinical Capability | High-Income Countries | Africa & Emerging Markets |
|---|---|---|
| Electronic Health Records | Universal, cloud-based, interoperable | Paper records, fragmented, lost |
| Clinical Decision Support | Real-time, integrated into workflow | Largely absent at point of care |
| Pharmacogenomics | Genetic testing widely available | No population-scale PGx infrastructure |
| Medical Imaging AI | AI-assisted radiology standard | 50% of population has no radiologist access |
| Drug Interaction Checking | Automated, pre-dispensing verification | Manual or absent |
| Traditional Medicine Data | Not applicable at scale | 80% use TM; zero CDS integration |
The Cost
This Is Not Just a Healthcare Problem. It Is an Economic One.
The World Bank estimates that the global economic loss from premature death and disability due to poor-quality healthcare exceeds $6 trillion annually. In Africa, where healthcare systems are already strained, every preventable death represents not only a tragedy but a compounding loss of productive capacity, family stability, and community resilience.
Clinical AI is not a luxury innovation for wealthy health systems. It is the most high-leverage intervention available to close this gap at scale.
See KEMIRIX’s Solution →